| Comparative diagnostic accuracy of 18F-FDG PET/CT for breast cancer recurrence R Piva, F Ticconi, V Ceriani, F Scalorbi, F Fiz, S Capitanio, M Bauckneht, ... Breast Cancer: Targets and Therapy 9, 461, 2017 | 36 | 2017 |
| Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors S Pusceddu, N Prinzi, S Tafuto, T Ibrahim, A Filice, MP Brizzi, F Panzuto, ... JAMA Network Open 5 (2), e220290-e220290, 2022 | 31 | 2022 |
| Predictive and prognostic value of 18F-DOPA PET/CT in patients affected by recurrent medullary carcinoma of the thyroid F Caobelli, A Chiaravalloti, L Evangelista, G Saladini, O Schillaci, ... Annals of nuclear medicine 32 (1), 7-15, 2018 | 19 | 2018 |
| Italian multicenter study on accuracy of 18F-FDG PET/CT in assessing bone marrow involvement in pediatric Hodgkin lymphoma A Cistaro, L Cassalia, C Ferrara, N Quartuccio, L Evangelista, M Bianchi, ... Clinical Lymphoma Myeloma and Leukemia 18 (6), e267-e273, 2018 | 15 | 2018 |
| Prognostic and diagnostic value of [18F] FDG-PET/CT in restaging patients with small cell lung carcinoma: an Italian multicenter study N Quartuccio, L Evangelista, P Alongi, F Caobelli, C Altini, A Cistaro, ... Nuclear medicine communications 40 (8), 808-814, 2019 | 9 | 2019 |
| Conventional MRI-derived biomarkers of adult-type diffuse glioma molecular subtypes: A comprehensive review P Feraco, R Franciosi, L Picori, F Scalorbi, C Gagliardo Biomedicines 10 (10), 2490, 2022 | 4 | 2022 |
| Update on radioligand therapy with 177Lu-PSMA for metastatic castration-resistant prostate cancer: clinical aspects and survival effects V Fuoco, G Argiroffi, S Mazzaglia, A Lorenzoni, V Guadalupi, A Franza, ... Tumori Journal, 03008916211037732, 2021 | 3 | 2021 |
| Application of FLIC model to predict adverse events onset in neuroendocrine tumors treated with PRRT F Scalorbi, G Argiroffi, M Baccini, L Gherardini, V Fuoco, N Prinzi, ... Scientific reports 11 (1), 1-10, 2021 | 2 | 2021 |
| Transarterial radioembolization of unresectable intrahepatic cholangiocarcinoma with Y-90 glass microspheres: results of a single institution study A Lorenzoni, S Mazzaglia, C Spreafico, F Scalorbi, G Argiroffi, S Bhoori, ... EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 47 (SUPPL 1 …, 2020 | 1 | 2020 |
| PRRT Safety and Disease Control Persistence: the Feasibility of Retreatment M Maccauro, A Capozza, G Aliberti, J Coppa, S Pusceddu, F Scalorbi, ... EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 46 (SUPPL 1 …, 2019 | 1 | 2019 |
| Correction to: Predictive and prognostic value of 18F-DOPA PET/CT in patients affected by recurrent medullary carcinoma of the thyroid. F Caobelli, A Chiaravalloti, L Evangelista, G Saladini, O Schillaci, ... Annals of nuclear medicine 32 (6), 430, 2018 | 1 | 2018 |
| The Wandering Mesenteric Lymph Node: Delayed 68Ga-DOTANOC PET/CT Imaging to Overcome a Potential Pitfall. L Zanoni, M Zompatori, F Scalorbi, S Fanti, V Ambrosini Clinical nuclear medicine 42 (5), e253-e254, 2017 | 1 | 2017 |
| Author Correction: Application of FLIC model to predict adverse events onset in neuroendocrine tumors treated with PRRT F Scalorbi, G Argiroffi, M Baccini, L Gherardini, V Fuoco, N Prinzi, ... Scientific Reports 13 (1), 1759, 2023 | | 2023 |
| Diagnostic Applications of Nuclear Medicine: Leukemias M Sollini, F Scalorbi, G Aghakhanyan, S Galimberti, R Boni, F Bartoli, ... Nuclear Oncology: From Pathophysiology to Clinical Applications, 529-567, 2022 | | 2022 |
| Investigation of miRNAs as outcome predictors in midgut NET treated with PPRT F Scalorbi, L Roz, G Pollaci, G Centonze, V Lagano, F Facchinetti, ... EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 48 (SUPPL 1 …, 2021 | | 2021 |
| 1105P Predictive factors of adverse events onset in GEPNET patients treated with PRRT F Scalorbi, G Argiroffi, A Lorenzoni, M Baccini, L Gherardini, V Fuoco, ... Annals of Oncology 32, S913, 2021 | | 2021 |
| 1112P Modified TGR: A new strong radiological marker to accurately predict early response to PRRT in GEPNETs F Scalorbi, G Calareso, E Garanzini, A Marchiano, E Seregni, ... Annals of Oncology 32, S916, 2021 | | 2021 |
| Single-institution real-life experience of 177Lu-DOTATATE treatment in progressive, well-differentiated GEP-NETs F Scalorbi, M Maccauro, A Lorenzoni, V Fuoco, G Argiroffi, N Prinzi, ... JOURNAL OF NEUROENDOCRINOLOGY 33, 195-195, 2021 | | 2021 |
| Single-institution real-life experience of Lu-177-DOTATATE treatment in progressive, well differentiated GEPNETs F Scalorbi, A Lorenzoni, E Seregni, V Fuoco, G Argiroffi, N Prinzi, ... EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 47 (SUPPL 1 …, 2020 | | 2020 |
| 1180P Single-institution real-life experience of 177Lu-DOTATATE treatment in progressive, well differentiated GEPNETs F Scalorbi, A Lorenzoni, V Fuoco, G Argiroffi, N Prinzi, S Pusceddu, ... Annals of Oncology 31, S780, 2020 | | 2020 |
